| abstract |
The invention relates to pharmaceutical compositions comprising one or more cannabinoids and a pharmaceutically acceptable carrier. The compositions are in a form suitable for topical administration, and may be used to treat pain. Cannabinoids suitable for this use include cannabidiols, cannabinols, and various other natural and synthetic cannabinoids. The compositions may also further comprise anti-inflammatory agents, steroids, or terpenoids. According to preferred embodiments, the cannabinoids incorporated in the compositions are cannabidiol (CBD) and cannabinol (CBN), and the vectors are selected from the group consisting of Labrasol ™, Transcutol ™, lecithin, lysolecithin, isopropyl palmitate and isopropyl myristate. |